Background/Objectives: Dietary supplements are commonly used in Japan. Although some dietary supplements can affect perioperative conditions due to abnormalities in the blood coagulation system, there are no reports examining the duration of withdrawal and the risk of complications during bronchoscopy. We aimed to retrospectively review the safety and withdrawal periods of supplements prior to bronchoscopy in patients who regularly consumed dietary supplements. Methods: This single-center retrospective observational study was conducted at Tottori University Hospital. Patients who underwent bronchoscopy between January 2019 and December 2019 were validated and examined. We examined patient backgrounds, in-cluding age, sex, underlying conditions, use of antithrombotic agents, consumption of di-etary supplements and the specific types of dietary supplements consumed, and the type of bronchoscopy procedure. Data regarding the duration of dietary supplement with-drawal and complications during and after bronchoscopy were also collected. Results: A total of 351 bronchoscopy procedures were performed during the observation period. Of these, 69 (23.3%) bronchoscopies were performed on patients who regularly used dietary supplements. There were 19 cases of invasive bronchoscopy in patients who regularly used dietary supplements with bleeding risk. The median withdrawal period for the dietary supplements was 14 days. The incidence of bleeding complications from inva-sive bronchoscopy did not differ significantly among the groups divided according to whether they took antithrombotic agents or dietary supplements with bleeding risk. Conclusions: Based on this retrospective analysis, dietary supplements may be considered safe if there is sufficient time to avoid taking them before undergoing invasive bronchoscopy.
Background Performance status is a useful prognostic index in palliative care. The objectives of this study were to investigate the prognosis of near-end-of-life patients with advanced lung cancer admitted due to deteriorated performance status, evaluate the utility of performance status measurement in predicting life expectancy, and identify prognostic factors using Bayesian proportional hazards models.Methods This prospective observational cohort study measured at admission, the Performance status, Palliative Performance Scale, Karnofsky Performance Status (KPS), Palliative Prognostic Index scores, and clinical biochemistry parameters of the included patients. Ninety-two patients with advanced lung cancer and deteriorated performance status admitted to our department at the NHO Yonago Medical Center between January 2016 and December 2018 were analyzed. Bayesian proportional hazards models were employed to classify remaining life prognoses. The Watanabe–Akaike information criteria (WAIC) with the lowest score was used to choose the final model.Results The median survival time was 25 (range, 1–107) days. The final prognostic model for the dying trajectory of patients was selected as an M-spline proportional hazards model according to the least WAIC. Independent prognostic factors for shorter remaining life were hypercalcinemia [hazard ratio (HR) 5.37, 95% confidence interval (CI) 2.11–12.9] and low KPS (HR 1.77, 95%CI 1.30–2.46).Conclusion Assessing hypercalcinemia and KPS can be advantageous for predicting near-end-of-life prognosis in terminally ill patients with advanced lung cancer.
Background: Dietary supplements are commonly used in Japan. Although some dietary supplements can affect perioperative conditions owing to abnormalities in the blood coagulation system, there are no reports examining the duration of withdrawal and the risk of complications during bronchoscopy. We aimed to retrospectively review the safety and withdrawal periods of supplements before bronchoscopy in patients who regularly consumed dietary supplements.Materials and Methods: This single-center retrospective observational study was conducted at Tottori University Hospital. Patients who underwent bronchoscopy between January 2019 and December 2019 were validated and examined. We examined patient backgrounds, including consumption of dietary supplements and the type of bronchoscopy procedure. Data regarding the duration of dietary supplement withdrawal and complications during and after bronchoscopy were also collected.Results: A total of 351 bronchoscopy procedures were performed during the observation period. Of these, 69 bronchoscopies (23.3%) were performed in patients who regularly used dietary supplements. There were 19 cases of invasive bronchoscopy in patients who regularly used dietary supplements with bleeding risk. The median withdrawal period for the dietary supplements was 14 days. The incidence of bleeding complications from invasive bronchoscopy did not differ significantly among the patients who took antithrombotic agents or dietary supplements with bleeding risk.Conclusions: On the basis of this retrospective analysis, dietary supplements may be considered safe if they are withdrawn at a significant interval (≥7 days) before patients undergo invasive bronchoscopy.